19 related articles for article (PubMed ID: 36645220)
1. Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
Song M; Qu Y; Jia H; Zhang Y; Liu S; Laster KV; Choi BY; Tian J; Gu T; Chen H; Liu K; Lee MH; Dong Z
Mol Carcinog; 2024 May; 63(5):991-1008. PubMed ID: 38376345
[TBL] [Abstract][Full Text] [Related]
2. Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma.
Yuan Q; Shi Y; Zhang Y; Shi Y; Hussain Z; Zhao J; Jiang Y; Qiao Y; Guo Y; Lu J; Dong Z; Dong Z; Wang J; Liu K
Cancer Cell Int; 2024 Mar; 24(1):114. PubMed ID: 38528618
[TBL] [Abstract][Full Text] [Related]
3. Daurisoline attenuates H
Zhang Y; Liu W; Liu Z; Liu Y
J Orthop Surg Res; 2023 Mar; 18(1):248. PubMed ID: 36973772
[TBL] [Abstract][Full Text] [Related]
4. Daurisoline Inhibiting Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Bladder Cancer by Mediating HAKAI Protein Stability.
Huang K; Chen Q; Deng L; Zou Q; Min S
Iran J Pharm Res; 2022 Dec; 21(1):e129798. PubMed ID: 36937208
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer.
Liang F; Xu H; Cheng H; Zhao Y; Zhang J
Cancer Gene Ther; 2023 Nov; 30(11):1443-1455. PubMed ID: 37537209
[TBL] [Abstract][Full Text] [Related]
6. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ
Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197
[TBL] [Abstract][Full Text] [Related]
7. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
9. Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
Jia X; Wang P; Huang C; Zhao D; Wu Q; Lu B; Nie W; Huang L; Tian X; Li P; Laster KV; Jiang Y; Li X; Li H; Dong Z; Liu K
J Exp Clin Cancer Res; 2023 Apr; 42(1):97. PubMed ID: 37088855
[TBL] [Abstract][Full Text] [Related]
10. Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase.
Yang N; Lu X; Jiang Y; Zhao L; Wang D; Wei Y; Yu Y; Kim MO; Laster KV; Li X; Yuan B; Dong Z; Liu K
Elife; 2022 Sep; 11():. PubMed ID: 36082941
[TBL] [Abstract][Full Text] [Related]
11. Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase.
Wang D; Zhang W; Zhang X; Li M; Wu Q; Li X; Zhao L; Yuan Q; Yu Y; Lu J; Zhao J; Dong Z; Liu K; Jiang Y
Mol Carcinog; 2023 Apr; 62(4):517-531. PubMed ID: 36645220
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
